RxDoctor Payments Data
★ My doctorsLook up a doctor →

Ellis Main

Family Medicine · Robstown, TXNPI 1366440919

Payments from drug & device makers

$4,845in general payments, 2019–2025

Across 329 payments — averaging $14.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AstraZeneca$528
  • AbbVie$498
  • Amarin Pharma, Inc.$349
  • Amgen$303
  • Johnson & Johnson$291
  • plus $2K from 23 others

What the payments were for

  • Food & beverage$4,79799%
  • Education$481%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk93$1,064
AstraZeneca31$528
AbbVie(2 entities)35$498
Amarin Pharma, Inc.17$349
Amgen(2 entities)20$303
Johnson & Johnson21$291
Esperion Therapeutics, Inc.8$226
Boehringer Ingelheim14$199
Lilly USA, LLC10$151
Merck11$136
Astellas Pharma US Inc10$128
GSK7$126
Sanofi-aventis U.S. LLC6$96
Takeda Pharmaceuticals U.S.A., Inc.9$95
Corcept Therapeutics5$92
Novartis4$77
CSL Behring3$66
Kowa Pharmaceuticals America, Inc.3$64
Pharming Healthcare, Inc.3$63
Teva Pharmaceuticals USA, Inc.3$44
Eisai Inc.3$41
Dexcom, Inc.2$34
Arbor Pharmaceuticals, Inc.2$31
Abbott2$31
Biohaven Pharmaceuticals, Inc.2$30
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC2$29
Inspire Medical Systems, Inc.1$21
Genentech USA, Inc.1$21
Shire North American Group Inc1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,845 in reported general payments places this provider in the 85th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas →

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol15$17,671
OzempicSemaglutide12$13,093
Gabapentin19$520
Omeprazole20$444
Lisinopril44$318
Albuterol Sulfate HfaAlbuterol Sulfate17$286
Duloxetine Hcl12$247
Metoprolol Tartrate26$206
Levothyroxine Sodium23$187
Atorvastatin Calcium40$183
ClopidogrelClopidogrel Bisulfate16$178
Metformin Hcl32$153
Simvastatin21$153
Clonazepam11$150
Amlodipine Besylate28$147

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$528$17,67115 claims
Novo NordiskOzempic$1,064$13,09312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Robstown

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →